M.D. ANDERSON CANCER CENTER

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

First Posted Date
2006-04-03
Last Posted Date
2016-09-23
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
469
Registration Number
NCT00310115
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Computer-Assisted Counseling in Helping African American Smokers Stop Smoking

First Posted Date
2006-04-03
Last Posted Date
2017-08-22
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
462
Registration Number
NCT00310141
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma

First Posted Date
2006-03-28
Last Posted Date
2012-07-31
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
28
Registration Number
NCT00307710
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

First Posted Date
2006-03-22
Last Posted Date
2015-12-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
11
Registration Number
NCT00305643
Locations
🇺🇸

Cancer Research for the Ozarks, Springfield, Missouri, United States

🇺🇸

CCOP - Columbus, Columbus, Ohio, United States

🇺🇸

CCOP - Kalamazoo, Kalamazoo, Michigan, United States

and more 11 locations

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

First Posted Date
2006-03-16
Last Posted Date
2015-11-26
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
76
Registration Number
NCT00303290
Locations
🇺🇸

The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer

First Posted Date
2006-03-10
Last Posted Date
2013-04-05
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
48
Registration Number
NCT00301028
Locations
🇺🇸

M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

First Posted Date
2006-03-06
Last Posted Date
2015-11-03
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
65
Registration Number
NCT00299156
Locations
🇺🇸

U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

First Posted Date
2006-03-06
Last Posted Date
2021-09-21
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
50
Registration Number
NCT00299182
Locations
🇺🇸

UT MD Anderson Cancer Center, Houston, Texas, United States

Group Therapy for Nicotine Dependence: Mindfulness and Smoking

First Posted Date
2006-02-28
Last Posted Date
2020-06-16
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
650
Registration Number
NCT00297479
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

Phase 1
Completed
Conditions
Interventions
First Posted Date
2006-02-22
Last Posted Date
2020-02-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
54
Registration Number
NCT00294632
Locations
🇺🇸

University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath